Cardiovascular Disease Prevention Disease Summary

Overview

In the Introduction section, it is stated that cardiovascular disease (CVD) risk assessment is essential for primary prevention.

CVD is the leading cause of death globally and is a major cause of morbidity worldwide. It is also the leading cause of death in different regions and countries in the world. Other details on its prevalence are found in the Epidemiology section.

The Pathophysiology section states that CVD is the result of the complex interplay of various factors such as genetics, immunologic phenomena, dyslipidemia, and endothelial dysfunction. While in the Risk Factors section, details on risk stratification, risk factors, and risk factor equivalents are discussed.

Cardiovascular Disease Prevention_Disease Summary

History and Physical Examination

In the History and Physical Examination sections, details on CVD risk assessment, primarily signs and symptoms of target organ damage (TOD) and atherosclerotic CVD (ASCVD) are discussed.

Diagnosis

As discussed in the Diagnosis and Diagnostic Criteria section, coronary risk charts are used to determine overall CVD risk.

The Laboratory Tests and Ancillaries and Imaging sections enumerate the tests that can be performed in assessing and evaluating a patient suffering from CVD.

Management

The Evaluation section describes the different CVD risk categories. While the Principles of Therapy details the selection of patients for early intervention and the management of risk factors.

The different drugs that can be used in CVD prevention are enumerated and discussed in the Pharmacological Therapy section.

Details on patient education and lifestyle modification for CVD are discussed in the Nonpharmacological section. Lastly, management of other risk factors is discussed in the Prevention section.